SAN FRANCISCO Calif. Nov. 2 2011 PRNewswire Nektar Therapeutics Nasdaq NKTR today reported its financial results for the third quarter ended September 30 2011. Cash cash equivalents and investments at September 30 2011 were $458.0 million as compared to $...
↧